These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 18957479)
41. Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report. Croissant B; Hermann D; Olbrich R Pharmacopsychiatry; 2005 Jan; 38(1):38-9. PubMed ID: 15706466 [TBL] [Abstract][Full Text] [Related]
42. Asymptomatic bradycardia associated with amisulpride. Pedrosa Gil F; Grohmann R; RĂ¼ther E Pharmacopsychiatry; 2001 Nov; 34(6):259-61. PubMed ID: 11778148 [TBL] [Abstract][Full Text] [Related]
43. Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient. Tei Y; Morita T; Inoue S; Miyata H Psychosomatics; 2004; 45(5):450-1. PubMed ID: 15345794 [No Abstract] [Full Text] [Related]
44. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake. Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428 [TBL] [Abstract][Full Text] [Related]
45. [Hemiparesis and torsade de pointes under low-dose sotalol therapy]. Sieber C; Weiss P; Follath F Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270 [TBL] [Abstract][Full Text] [Related]
46. Tiapride-induced torsade de pointes. Iglesias E; Esteban E; Zabala S; Gascon A Am J Med; 2000 Oct; 109(6):509. PubMed ID: 11184770 [No Abstract] [Full Text] [Related]
47. Torsade de pointes associated with encephalitis. Alehan D; Ceviz N; Celiker A Turk J Pediatr; 1999; 41(3):395-8. PubMed ID: 10770105 [TBL] [Abstract][Full Text] [Related]
48. Antipsychotics and QTc interval prolongation. White CM Conn Med; 2002 Aug; 66(8):461-3. PubMed ID: 12407956 [No Abstract] [Full Text] [Related]
50. Long QTc interval and torsade de pointes caused by fluconazole. Pham CP; de Feiter PW; van der Kuy PH; van Mook WN Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620 [TBL] [Abstract][Full Text] [Related]
53. Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. Poluzzi E; Raschi E; Koci A; Moretti U; Spina E; Behr ER; Sturkenboom M; De Ponti F Drug Saf; 2013 Jun; 36(6):467-79. PubMed ID: 23553446 [TBL] [Abstract][Full Text] [Related]
54. Amisulpride induced agranulocytosis: a case report. Pickard L; Fordham N; Koh M Ann Hematol; 2016 Jun; 95(7):1193-5. PubMed ID: 27052990 [No Abstract] [Full Text] [Related]
55. Torsade or not torsade? That is the question. Verdino RJ Arch Intern Med; 1998 Jul; 158(14):1578-9. PubMed ID: 9679804 [No Abstract] [Full Text] [Related]
57. Potential torsades de pointes triggered by hypokalemia related to olanzapine in a patient with implantable cardioverter-defibrillator. Huang G; Fu Q; Xu J J Clin Psychopharmacol; 2014 Oct; 34(5):651-2. PubMed ID: 25127223 [No Abstract] [Full Text] [Related]
58. Asymptomatic bradycardia and hypotension associated with amisulpride: A case report. Su CH; Chen CS; Huang MF Asia Pac Psychiatry; 2016 Jun; 8(2):175. PubMed ID: 27062666 [No Abstract] [Full Text] [Related]